Dyne Therapeutics Stock Quote DYN - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

44.50

Bid

39.87

Ask

46.00

Volume

955,487

42.84 Day's Range 44.88

6.40 52 Week Range 45.455

Market Cap

3.889B

Previous Close

42.70

Open

43.36

Last Trade

44.5

Last Trade Time

Financial Volume

$ 42,374,431

VWAP

44.3485

Average Volume (3m)

1,224,286

Shares Outstanding

87,382,638

Dividend Yield

PE Ratio

-16.51

Earnings Per Share (EPS)

-2.7

Revenue

Net Profit

-235.94M

Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.dyne-tx.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Dyne Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DYN. The last closing price for Dyne Therapeutics was $42.70. Over the last year, Dyne Therapeutics shares have traded in a share price range of $ 6.40 to $ 45.455.

Dyne Therapeutics currently has 87,382,638 shares outstanding. The market capitalization of Dyne Therapeutics is $3.73 billion. Dyne Therapeutics has a price to earnings ratio (PE ratio) of -16.51.

Dyne Therapeutics Presents New Preclinical Data Demonstrating the Potential of the FORCE™ Platform to Deliver Enzyme Replacement Therapy to Muscle and CNS in Pompe Disease

WALTHAM, Mass., June 24, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics...

Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress

- Leveraging the FORCE™ Platform, DYNE-302 Achieved Robust and Durable DUX4 Suppression and Functional Benefit in FSHD Preclinical Models - WALTHAM, Mass., June 13, 2024 (GLOBE NEWSWIRE...

Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

WALTHAM, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq:DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	3.04	7.332368548	41.46	45.455	41.13	928717	42.9846506	CS
4	9.41	26.8167569108	35.09	45.455	33.0875	975368	40.23086383	CS
12	18.5	71.1538461538	26	45.455	24.93	1224286	33.86852502	CS
26	26.5	147.222222222	18	45.455	17.27	1298936	28.92579024	CS
52	34.08	327.063339731	10.42	45.455	6.4	1158499	22.13543426	CS
156	24.98	127.971311475	19.52	45.455	4.3	576633	18.70456233	CS
260	21.05	89.7654584222	23.45	45.455	4.3	519292	18.81688524	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WINTWindtree Therapeutics Inc	$ 8.24 (150.46%)	48.57M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NBSTWNewbury Street Acquisition Corporation	$ 0.1349 (92.71%)	122.1k
YIBOPlanet Image International Ltd	$ 2.915 (53.43%)	260.07k
CREVCarbon Revolution Public Ltd	$ 9.00 (45.87%)	8.06M
NMHINatures Miracle Holding Inc	$ 0.2035 (-48.06%)	7.69M
TANHTantech Holdings Ltd	$ 0.2585 (-47.23%)	6.75M
DXCMDexCom Inc	$ 64.00 (-40.66%)	53.92M
PSIGPS International Group Ltd	$ 1.42 (-31.40%)	716.26k
POAIPredictive Oncology Inc	$ 1.36 (-27.27%)	6.02M
SLNASelina Hospitality PLC	$ 0.0305 (-18.88%)	408.61M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NVDANVIDIA Corporation	$ 113.06 (0.69%)	293.33M
SQQQProShares UltraPro Short QQQ	$ 9.10 (-2.88%)	176.49M
SGMOSangamo Therapeutics Inc	$ 0.8612 (28.15%)	123.71M